The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older ...

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new ...

Scientists have, for the first time, tracked nasal insulin traveling into the brain—revealing why it may work differently in ...

The FDA's nasal decongestants drug list, or monograph, has not been updated since 1995. The process for changing a monograph has traditionally taken years or decades, requiring multiple rounds of ...

A new medication related to the iconic party drug "Special K" that can rapidly treat depression could revolutionize the treatment of the condition affecting more than 16 million Americans, experts ...

A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free ...

The first sumatriptan nasal spray, sold under the brand name Imitrex, was approved by the U.S. Food and Drug Administration (FDA) in 1997, but it was discontinued in January 2024.

(CNN) — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens<a ...

The nasal spray has shown promise in treating depression when other meds don't. Popularly known as the street drug “Special-K,” ketamine is often used in hospitals as an anesthetic, too. But ...

The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and similar ...